FOXM1 and neoplasm: Third, FOXM1 mediates tumor cell resistance to irradiation [120], chemotherapies [126,127], and targeted therapeutics, including PI3K inhibitors [128,129], EGFR inhibitors [123], and CDK4/6 inhibitors [67,129], among others.